AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madebo, T.
Right arrow Articles by Berge, R. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madebo, T.
Right arrow Articles by Berge, R. K
Agricola
Right arrow Articles by Madebo, T.
Right arrow Articles by Berge, R. K
American Journal of Clinical Nutrition, Vol. 78, No. 1, 117-122, July 2003
© 2003 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia1,2,3

Tesfaye Madebo, Bernt Lindtjørn, Pål Aukrust and Rolf K Berge

1 From the Center for International Health (TM and BL) and the Department of Clinical Biochemistry (RKB), University of Bergen, Bergen, Norway; Yirga Alem Hospital, Yirga Alem, Ethiopia (TM and BL); the Department of Medicine, Rogaland Central Hospital, Stavanger, Norway (TM); and the Section of Clinical Immunology and Infectious Disease and the Research Institute for Internal Medicine, University of Oslo, The National Hospital, Rikshospital, Oslo (PA).

2 Supported by the University of Bergen and Helse-Vest Norway (grant HRV19910).

3 Address reprint requests to T Madebo, Department of Medicine, Rogaland Central Hospital, PO Box 8100, Armauer Hansensvei 20, 4068 Stavanger, Norway. E-mail: tesfaye.madebo{at}cih.uib.no.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Knowledge of the antioxidant profile and its relation to lipid peroxidation in tuberculosis patients with or without accompanying HIV infection is scarce, particularly in developing countries.

Objective: The objective was to further investigate the interaction between HIV, tuberculosis, and antioxidants and their relations with markers of oxidative stress in a large population of Ethiopians.

Design: In a cross-sectional study, we evaluated antioxidants and markers of oxidative stress in Ethiopian tuberculosis patients with (n = 25) and without (n = 100) HIV infection and in Ethiopian (n = 45) and Norwegian (n = 25) healthy control subjects.

Results: Concentrations of the antioxidant vitamins C and E and of vitamin A were significantly lower in tuberculosis patients than in healthy Ethiopians. Tuberculosis patients also had significantly lower thiol concentrations, particularly of the reduced forms. Tuberculosis patients, particularly those who were co-infected with HIV, had higher malondialdehyde concentrations than did control subjects. High malondialdehyde concentrations were associated with clinical severity as measured by the Karnofsky Performance Status Index and anthropometric scores. Ethiopian control subjects had lower concentrations of vitamin E and higher concentrations of malondialdehyde than did Norwegian control subjects.

Conclusions: Our findings further support a link between oxidative stress, tuberculosis, and HIV infection. However, whether antioxidant supplementation will improve tuberculosis outcome or is of importance for its prevention should be further examined in future prospective studies.

Key Words: Tuberculosis • HIV • malnutrition • glutathione • antioxidants • oxidative stress


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
HIV infection is characterized by progressive immunodeficiency. The immunologic hallmark of HIV infection is a numerical and functional decline in CD4+ T cells, which over time leads to the development of AIDS. Several factors seem to be involved in the pathogenesis of HIV infection, and we and others have suggested that oxidative stress may play an important role in this process (1–3). Several studies have reported decreased antioxidant concentrations, disturbed glutathione metabolism, and enhanced spontaneous generation of reactive oxygen species (ROSs) in HIV-infected patients. Moreover, it was shown that supplementation with glutathione or antioxidants may improve immunologic and virologic indexes in HIV-infected persons (4).

An alarming epidemic of tuberculosis has followed the rapid rise in HIV/AIDS cases, particularly in developing countries such as Ethiopia. Mycobacterium can induce ROS production by activating phagocytes (5–7), and although an important part of the host defense against mycobacteria, enhanced ROS generation may promote tissue injury and inflammation. This further contributes to immunosuppression (8–10), particularly in those with impaired antioxidant capacity, such as HIV-infected patients (1, 2, 4). Moreover, the malnutrition that commonly occurs in Ethiopian patients with tuberculosis or HIV infection may further contribute to the impaired antioxidant capacity in these patients.

Examination of antioxidants in patients with HIV infection and tuberculosis may identify deficiencies that predispose to severe oxidant injury and immunodeficiency. However, our knowledge of the antioxidant profile and its relation to lipid peroxidation in tuberculosis patients with or without accompanying HIV infection is scarce, particularly in developing countries. Thus, to further study the interaction between HIV, tuberculosis, and antioxidants, we investigated antioxidant status and its relation to lipid peroxidation products in Ethiopian tuberculosis patients with or without HIV infection.


   SUBJECTS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Patient selection
From July to December 1995 we studied 239 consecutively identified pulmonary tuberculosis patients in Ethiopia (11). Tuberculosis was considered proven when a patient had signs of clinical and radiologic pulmonary tuberculosis, including positive Ziehl Neelsen staining of sputum showing acid-fast bacilli (12). In a cross-sectional study, we selected patients on the basis of a coin toss. After the patients were recruited for study, they were randomly assigned for analysis of antioxidants and lipid peroxidation products depending on the results of the coin toss. The patients included in the antioxidant substudy were later compared with the whole study population with respect to variables such as age, sex, HIV serostatus, malnutrition, and treatment outcomes, and the 2 groups were not significantly different regarding these variables. Forty-five healthy blood donors (38 men, 7 women; ± SD age: 31 ± 11.6 y) from the same area were recruited as control subjects. As an additional control group, we included blood samples from 25 healthy Norwegian blood donors (21 men, 4 women; ± SD age: 34.7 ± 10.6 y). All blood donors identified themselves as healthy volunteers for blood donation. After a routine interview to exclude individuals with all types of acute or chronic disease, the blood donors underwent structured clinical and some basic laboratory examination to exclude those with HIV infection or diseases that can be transmitted with blood transfusion, such as hepatitis.

None of the tuberculosis patients or the Ethiopian control subjects were using any kind of treatment or prophylaxis for chronic disease, such as hypertension, diabetes mellitus, coronary artery disease, HIV infection, or other diseases that could affect the results of our analysis. In the patient group, all blood samples were taken before the start of tuberculosis treatment.

Informed consent for participating in the study was obtained from all patients and control subjects. The study was approved by the National AIDS Control Program and the National Tuberculosis Control Program of Ethiopia.

Treatment, follow-up, and recording of treatment outcomes
After their tuberculosis was diagnosed, the patients were treated according to standard protocol at the hospital (13). Patients in whom supervised therapy was feasible were given short-course chemotherapy DOTS (directly observed treatment–short course), ie, rifampicin, isoniazid, pyrazinamide, and streptomycin, for 2 mo followed by 6 mo of treatment with isoniazid and thioacetazone. The other patients were given long-course chemotherapy (2 mo with isoniazid, thioacetazone, and streptomycin followed by 10 mo with isoniazid and thioacetazone). Short-course chemotherapy was given to all patients with previous treatment failure on long-course chemotherapy.

We assessed and categorized treatment outcomes as cured (n = 25; patients who were smear-negative at the completion of treatment and on at least one previous occasion), treatment completed (n = 24; patients who had completed treatment but without proof of cure), treatment failure (n = 1; patients who remained or became smear-positive 5 mo or later during treatment), died (n = 5; patients who died for any reason during treatment), treatment interrupted ("defaulter," n = 29; patients whose treatment was interrupted for ≥ 2 mo), and transferred out (n = 41; patients who were transferred to another treatment unit and for whom the treatment outcome was unknown) (13).

Investigation of patients
Standardized procedures were used to measure body weight, height, and midupper arm circumference (14). The weighing scales were calibrated regularly, and all subjects were weighed while wearing minimal clothing. Body mass index (BMI; in kg/m2) values of 18.5, 17.0, and 16.0 were used as the thresholds below which patients were classified as having mild, moderate, or severe malnutrition (14). Patients with a midupper arm circumference < 24 cm for men and < 23 cm for women were considered malnourished (14). In addition, dietary intakes were estimated by a dietary and history interview procedure with the use of a modified food-frequency questionnaire (15) that included a food list adapted to include foods commonly consumed in south Ethiopia. The subjects were specifically questioned about the number of daily eating occasions and how often they consumed meat, milk, cereals, fruit, legumes, vegetables, and enset (Ensete ventricosum, or false banana). Enset is the most common traditional food in this rural area. Functional status assessments were based on the Karnofsky Performance Status Index, which rates functional status at 10-point intervals from 0 to 100.

Protocol for blood sampling, transport, and storage
Peripheral venous blood was drawn into sterile vacuum tubes without additives between 0800 and 1000 after the subjects had fasted overnight. The tubes were kept at 4 °C until clotting occurred (< 1 h) and were then centrifuged (400 x g, 10 min, 4 °C); serum was stored at -80 °C (Norway) or -20 °C (Ethiopia). After storage at -20 °C for < 3 wk, the Ethiopian samples were transported on dry ice to Armauer Hansen Research Institute (Addis Ababa, Ethiopia) for storage at -80 °C. Samples were later transported on dry ice to Bergen, Norway, and were stored at -80 °C until analyzed. All samples were protected from light with aluminum foil during transport and processing and were thawed only once.

Biochemical analysis
Hematocrit, albumin, alkaline phosphatase, total bilirubin, {gamma}-glutamyltransferase, creatinine, triacylglycerol, and cholesterol were measured by standard techniques. C-reactive protein measurement was based on liquid-phase immunoprecipitation (Orion Diagnostic, Espoo, Finland). Ferritin was measured by heterogeneous sandwich magnetic separation assay (Bayer, New York).

Measurements of vitamins A, C, and E
Serum retinol and {alpha}-tocopherol were measured simultaneously by an HPLC method (16). For measurement of ascorbic acid, serum was stabilized with an equal volume of 10% meta-phosphoric acid. The precipitate was removed by centrifugation for 5 min (4000 x g at 4 °C), and the supernatant fluid was kept at -80 °C until the analysis of ascorbic acid by HPLC with colorimetric detection (17, 18).

Thiol analyses
Total and reduced glutathione, cysteine, and cysteinylglycine were quantified after derivitization of samples with the fluorescent agent monobromobimane (Molecular Probes, Eugene, OR) by reversed-phase HPLC as described (19).

Malondialdehyde measurement
Plasma concentrations of malondialdehyde (MDA) as thiobarbituric acid complexes were measured by HPLC (20). To prevent peroxidation during the assay, the chain-breaking antioxidant butylated hydroxytoluene was added to the samples at the start of the assay.

Statistical analysis
Statistical analyses were performed by using SPSS for WINDOWS, version 9.0.0 (21). In addition, SIGMAPLOT graphing software (SPSS Inc, Chicago) was used to compare groups by using means and CIs. Data are presented as means with 95% CIs or as means ± SDs unless stated otherwise. To obtained normal distributions, some variables (eg, ascorbic acid, vitamin A, total bilirubin, total and reduced cysteine, {gamma}-glutamyltransferase, and ferritin) were log-transformed. Statistical comparisons between the groups were assessed by one-way analysis of variance (ANOVA) for normally distributed and log-transformed data followed by Tukey’s test. Correlations between variables were calculated by Pearson’s correlation test for normally distributed variables and by the Spearman rank test for variables that were not normally distributed. P values are two-sided and were considered statistically significant when the {alpha} level was < 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Values for the clinical, hematologic, and biochemical indexes measured in the study group are shown in Table 1Go. Tuberculosis patients with or without HIV infection had significantly lower values for anthropometric (eg, weight, BMI, and midupper arm circumference), functional (Karnofsky Performance Status Index), and some biochemical (eg, albumin and hematocrit) indexes than did healthy Ethiopian control subjects. Tuberculosis patients with or without HIV infection also had significantly higher concentrations of ferritin, alkaline phosphatase, {gamma}-glutamyltransferase, and C-reactive protein than did the healthy control subjects, with particularly high ferritin and C-reactive protein concentrations in the HIV-infected group. This latter group also had significantly higher concentrations of {gamma}-glutamyltransferase than did the HIV-seronegative tuberculosis patients.


View this table:
[in this window]
[in a new window]
  		TABLE 1 Clinical, hematologic, and biochemical indexes in the study group1
 
Antioxidant concentrations
As shown in Table 2Go, serum concentrations of the antioxidant vitamins C and E and of vitamin A, a vitamin with no antioxidant capacity, were markedly lower in patients with tuberculosis than in healthy Ethiopian control subjects. Thiols, particularly glutathione, representing the major intracellular redox buffering compounds, were also significantly lower in tuberculosis patients, with particularly low concentrations of the reduced thiol forms. Notably, these alterations in vitamins and thiols were seen in both HIV-seropositive and HIV-seronegative tuberculosis patients, with no significant differences between these groups (data not shown).


View this table:
[in this window]
[in a new window]
  		TABLE 2 Serum concentrations of thiols and vitamins in patients with pulmonary tuberculosis (TB) and in healthy Ethiopian and Norwegian control subjects1
 
Concentrations of malondialdehyde and its association with circulating antioxidants
As shown in Figure 1Go, serum MDA concentrations, as a measure of lipid peroxidation reflecting the degree of oxidative stress, were significantly higher in patients with tuberculosis than in healthy Ethiopian control subjects, with particularly high concentrations in those who were co-infected with HIV. In tuberculosis patients, there were weak but significant inverse correlations between MDA and vitamin A (r = -0.23, P < 0.01), reduced glutathione (r = -0.27, P < 0.01), and reduced cysteine (r = -0.21, P < 0.01).



View larger version (6K):
[in this window]
[in a new window]
  		FIGURE 1. Mean (95% CI) serum concentrations of malondialdehyde (MDA) in HIV-seropositive (HIV+, n = 25) and HIV-seronegative (HIV-, n = 100) Ethiopian patients with pulmonary tuberculosis (TB+) and in Ethiopian (n = 45) and Norwegian (n = 25) healthy control (contr) subjects. *Significantly different from HIV-TB+ patients, P < 0.001 (ANOVA and Tukey’s test). **Significantly different from Ethiopian control subjects, P < 0.002 (ANOVA and Tukey’s test). {dagger}Significantly different from Norwegian control subjects, P < 0.003 (ANOVA and Tukey’s test). P for ANOVA < 0.001.

 
Oxidative stress and antioxidants in relation to nutritional state
Malnutrition may influence antioxidant concentrations and oxidative stress. As shown in Table 3Go, in patients with tuberculosis, but not in healthy Ethiopian control subjects, there was a weak but significant inverse association between low BMI and low weight and high MDA concentrations. Moreover, BMI was positively correlated with concentrations of vitamin E and the reduced thiols. Low vitamin A concentrations were strongly correlated with low values of all anthropometric variables, suggesting a strong association between vitamin A deficiency and malnutrition in these patients.


View this table:
[in this window]
[in a new window]
  		TABLE 3 Correlations between antioxidants, markers of oxidative stress, and anthropometric scores in 125 Ethiopian patients with pulmonary tuberculosis1
 
Oxidative stress in relation to clinical severity and outcome
Higher MDA concentrations were associated with poor clinical performance status (Karnofsky Performance Status Index) in the patient group as whole (r = -0.23, P < 0.01), regardless of accompanying HIV infection. There were no significant differences between the different treatment outcome groups (see Subjects and Methods) in serum concentrations of MDA, thiols, or vitamins (data not shown).

Comparison between healthy blood donors in Ethiopia and Norway
To further investigate the relations between antioxidants and oxidative stress in the Ethiopian population, we compared these variables in Ethiopian and Norwegian healthy blood donors. As shown in Table 2Go, concentrations of the antioxidant vitamin E, but not of vitamins A and C, were significantly lower and MDA concentrations were significantly higher (Figure 1Go) in Ethiopian than in Norwegian blood donors. Several thiol variables, especially the reduced form of cysteine, were also significantly lower in Ethiopian than in Norwegian healthy control subjects (Table 2Go). Several of the measured variables (eg, vitamin C) are sensitive to blood sampling and storage procedures. However, our findings of low vitamin E and some thiols but not of vitamin A and vitamin C in Ethiopian blood donors suggest that the differences in concentrations of antioxidants and MDA between the Ethiopian and Norwegian blood donors do not merely reflect differences in blood sampling protocols (see Subjects and Methods).


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
To our knowledge, the present study is the most comprehensive evaluation to date of circulating concentrations of antioxidants and markers of oxidative stress in tuberculosis patients in developing countries. Our results show lower antioxidant potential and enhanced lipid peroxidation in these patients, with particularly high concentrations of lipid peroxidation products (ie, MDA) in those who were co-infected with HIV. Moreover, we found that healthy Ethiopian control subjects had lower antioxidant and higher MDA concentrations than did healthy Norwegian control subjects. Our findings further support a role for oxidative stress in the pathogenesis of tuberculosis and suggest lower antioxidant capacity and higher oxidative stress in the Ethiopian than in the Norwegian population.

We did not systematically control for all of the possible confounding factors that could influence the concentrations of antioxidants and markers of oxidative stress. Some of these factors, however, such as the use of medications and differences in diet, may have had little effect in our study because none of the tuberculosis patients or Ethiopian control subjects were using any kind of treatment or prophylaxis for chronic diseases. Moreover, blood samples in the patient group were collected before the start of tuberculosis therapy. Furthermore, we found no significant difference in the pattern of usage of cereals, vegetables, legumes, fruit, milk, meat, and enset between the tuberculosis patients and the Ethiopian control subjects. However, the reporting of food consumption frequencies has inherent limitations because of recall biases, which in turn depend on functioning of memory and cognitive processes (22). We have no data on the smoking status or fatty acid profile of our study population, although smoking is not common in the area. Nevertheless, although the present study suggests a relation between lower antioxidant status and enhanced oxidative stress and tuberculosis, it does not prove a direct link between these variables. In addition to including more systematic adjustment for potential confounders, future studies should include more mechanistic experiments.

Tuberculosis has been reported to enhance HIV replication and the progression to AIDS in dually infected patients, possibly involving enhancement of inflammatory cytokines such as tumor necrosis factor {alpha} (23, 24). In the present study, we showed that co-infected patients also had higher concentrations of MDA than did HIV-seronegative tuberculosis patients, possibly reflecting increased oxidative stress in the former group. In contrast, antioxidant concentrations were not significantly different between these groups. Although we cannot exclude the possibility that HIV infection in Ethiopia is associated with low concentrations of antioxidants not measured in the present study, such as selenium, these findings suggest that ongoing tuberculosis infection has a greater impact on antioxidant status than on HIV infection per se. Nevertheless, this combination of enhanced oxidative stress and decreased concentrations of several antioxidants may have important pathogenic consequences in HIV-infected tuberculosis patients. Oxidative stress has been shown to enhance HIV replication (25), to induce the production of several inflammatory cytokines (25, 26), and to promote lymphocyte apoptosis (27) and T cell dysfunction (28) and could therefore contribute to increased viral replication and progression of immunodeficiency in patients dually infected with HIV and tuberculosis.

Reduced concentrations of vitamin A and of the antioxidant vitamins C and E were previously reported in patients with tuberculosis (29–31). We extend these findings by showing a significant reduction in several thiol metabolites in tuberculosis patients, with particularly low concentrations of the reduced forms. Several factors—such as low food intake, nutrient malabsorption, and inadequate nutrient release from the liver; acute-phase response and infection; and an inadequate availability of carrier molecules—may influence circulating antioxidant concentrations (32–34). Our findings of a correlation between several indexes of malnutrition and low concentrations of antioxidants may suggest the involvement of low food intake and nutrient malabsorption in the generation of oxidative stress in Ethiopian tuberculosis patients. Increased ROS generation was previously reported in patients with tuberculosis (5, 7, 8). Furthermore, our finding of a significant correlation between high MDA concentrations and low concentrations of some antioxidants suggests increased utilization by ROSs as an important contributing factor to the lower concentrations of antioxidants in tuberculosis patients. In fact, the combination of malnutrition leading to decreased "supplementation" of antioxidants and enhanced ROS generation leading to increased utilization of these compounds may represent a pathogenic loop that results in markedly enhanced oxidative stress during tuberculosis infection. Three of the antioxidants that were significantly reduced in tuberculosis patients, ie, glutathione, ascorbic acid, and {alpha}-tocopherol, are integral components of a regenerating redox cycle (35–37). Thus, a combined decrease in these antioxidants may markedly decrease antioxidant capacity in these patients. Moreover, water-soluble antioxidants such as glutathione and vitamin C and the lipid-soluble vitamin E may act synergistically to protect cells from oxidative-stress-induced damage (38). Accordingly, the combined deficiency of these antioxidants may markedly increase oxidative stress, possibly adversely affecting the immune response and predisposing to drug toxicity (39).

In the present study, concentrations of antioxidant vitamins and of several thiol compounds were lower and concentrations of MDA were higher in Ethiopian than in Norwegian control subjects. Malnutrition is more common in the Ethiopian community studied than in the Norwegian one, which may explain the differences in antioxidant concentrations. However, there was no significant difference in serum concentrations of vitamin A, a vitamin with no antioxidant effect, suggesting that the lower antioxidant concentrations in the Ethiopians may reflect more than merely malnutrition. It was previously reported that HIV-seronegative Africans are characterized by higher concentrations of inflammatory cytokines than those found in healthy Europeans (40, 41), and we showed that Africans also have indications of increased oxidative stress. This persistent immune activation and enhancement of oxidative stress may reflect 2 interacting phenomena possibly secondary to an increased infectious load in African populations.

In summary, we showed lower antioxidant potential and greater lipid peroxidation in Ethiopian tuberculosis patients than in Ethiopian control subjects, with particularly high concentrations of lipid peroxidation products in those who were co-infected with HIV. These findings further support a link between oxidative stress, tuberculosis, and HIV infection. Whether antioxidant supplementation will improve tuberculosis outcome or is of importance for its prevention, however, should be examined in future prospective studies.


   ACKNOWLEDGMENTS
 
We thank Randi Sandvik, Svein Kruger, and Bjorn Netteland for excellent technical assistance and acknowledge all of the technical assistance received at Armuer Hansen Research Institute, Addis Ababa, Ethiopia, and the Blood Bank at Yirga-Alem Hospital.

TM, BL, and RKB had the idea for this study and participated in the conception, design, data collection, statistical analysis, interpretation of results, and writing of the report. PA participated in study design, analysis and interpretation of results, and writing of the report and also provided the data related to the Norwegian blood donors. None of the authors had a conflict of interest.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 SUBJECTS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994;91:165–80.[Medline]
  2. Aukrust P, Muller F. Glutathione redox disturbances in human immunodeficiency virus infection: immunologic and therapeutic consequences. Nutrition 1999;15:165–7.[Medline]
  3. Muller F, Aukrust P, Svardal AM, Berge RK, Ueland PM, Froland SS. The thiols glutathione, cysteine, and homocysteine in human immunodeficiency virus (HIV) infection. In: Watson RD, ed. Nutrients, food and alternative medicines for AIDS. 1st ed. New York: CRC Press, 1998:35–69.
  4. Muller F, Svardal AM, Nordoy I, Berge RK, Aukrust P, Froland SS. Virological and immunological effects of antioxidant treatment in patients with HIV infection. Eur J Clin Invest 2000;30:905–14.[Medline]
  5. May ME, Spagnuolo PJ. Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect Immun 1987;55:2304–7.[Abstract/Free Full Text]
  6. Attwood EM, Weich DJ, Oosthuizen JM. The influence of carbon particles on the concentration of acid phosphatase and lysozyme enzymes within alveolar macrophages during the killing and degradation of Mycobacterium bovis. Tuber Lung Dis 1996;77:341–7.[Medline]
  7. Kuo HP, Ho TC, Wang CH, Yu CT, Lin HC. Increased production of hydrogen peroxide and expression of CD11b/CD18 on alveolar macrophages in patients with active pulmonary tuberculosis. Tuber Lung Dis 1996;77:468–75.[Medline]
  8. Jack CI, Jackson MJ, Hind CR. Circulating markers of free radical activity in patients with pulmonary tuberculosis. Tuber Lung Dis 1994;75:132–7.[Medline]
  9. Grimble RF. Malnutrition and the immune response. 2. Impact of nutrients on cytokine biology in infection. Trans R Soc Trop Med Hyg 1994;88:615–9.[Medline]
  10. Nathan CF, Brukner LH, Silverstein SC, Cohn ZA. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med 1979;149:84–99.[Abstract/Free Full Text]
  11. Madebo T, Nysaeter G, Lindtjørn B. HIV infection and malnutrition change the clinical and radiological features of pulmonary tuberculosis. Scand J Infect Dis 1997;29:355–9.[Medline]
  12. WHO. Treatment of tuberculosis: guidelines for national TB programs. Geneva: WHO, 1997.
  13. Ministry of Health. Guideline for the National Tuberculosis Control Program in Ethiopia. Addis Ababa, Ethiopia: Ministry of Health, Ethiopia, 1992.
  14. Report of a WHO Expert Committee. Physical status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser 1995;854.
  15. Hartog AP, Staveren WA. Manual for social surveys on food habits and consumption in developing countries. Wageningen, Netherlands: Pudoc, 1985.
  16. Arnaud J, Fortis I, Blachier S, Kia D, Favier A. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr 1991;572:103–16.[Medline]
  17. Tanishima K, Kita M. High-performance liquid chromatographic determination of plasma ascorbic acid in relationship to health care. J Chromatogr 1993;613:275–80.[Medline]
  18. Liau LS, Lee BL, New AL, Ong CN. Determination of plasma ascorbic acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr 1993;612:63–70.[Medline]
  19. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992;200:218–29.[Medline]
  20. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212–6.[Medline]
  21. Norusis MJ. SPSS base 9.0 for Windows user’s guide. Chicago: SPSS Inc, 1999.
  22. Drewnowski A, Hann C. Food preferences and reported frequencies of food consumption as predictors of current diet in young women. Am J Clin Nutr 1999;70:28–36.[Abstract/Free Full Text]
  23. Wallis RS, Ellner JJ, Shiratsuchi H. Macrophages, mycobacteria and HIV: the role of cytokines in determining mycobacterial virulence and regulating viral replication. Res Microbiol 1992;143:398–405.[Medline]
  24. Kitaura H, Ohara N, Kobayashi K, Yamada T. TNF-alpha-mediated multiplication of human immunodeficiency virus in chronically infected monocytoid cells by mycobacterial infection. Apmis 2001;109:533–40.[Medline]
  25. Israel N, Gougerot-Pocidalo MA. Oxidative stress in human immunodeficiency virus infection. Cell Mol Life Sci 1997;53:864–70.[Medline]
  26. Li N, Karin M. Is NF-{kappa}B the sensor of oxidative stress? FASEB J 1999;13:1137–43.[Abstract/Free Full Text]
  27. Famularo G, De Simone C, Marcellini S. Apoptosis: mechanisms and relation to AIDS. Med Hypotheses 1997;48:423–9.[Medline]
  28. Aukrust P, Svardal AM, Muller F, et al. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 1995;86:258–67.[Abstract/Free Full Text]
  29. Plit ML, Theron AJ, Fickl H, van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 1998;2:590–6.[Medline]
  30. Rwangabwoba JM, Fischman H, Semba RD. Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. Int J Tuberc Lung Dis 1998;2:771–3.[Medline]
  31. Dubey SS, Sinha KK, Gupta JP. Vitamin C status, glutathione and histamine in gastric carcinoma, tuberculous enteritis and non-specific ulcerative colitis. Indian J Physiol Pharmacol 1985;29:111–4.[Medline]
  32. Rock CL, Jacob RA, Bowen PE. Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J Am Diet Assoc 1996;96:693–704.[Medline]
  33. Sies H, Stahl W. Vitamins E and C, ß-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995;62(suppl):1315S–21S.[Abstract/Free Full Text]
  34. Das BS, Thurnham DI, Das DB. Plasma {alpha}-tocopherol, retinol, and carotenoids in children with falciparum malaria. Am J Clin Nutr 1996;64:94–100.[Abstract/Free Full Text]
  35. Winkler BS, Orselli SM, Rex TS. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Radic Biol Med 1994;17:333–49.[Medline]
  36. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994;269:9397–400.[Free Full Text]
  37. Niki E, Noguchi N, Tsuchihashi H, Gotoh N. Interaction among vitamin C, vitamin E, and ß-carotene. Am J Clin Nutr 1995;62(suppl):1322S–6S.[Abstract/Free Full Text]
  38. Di Mascio P, Murphy M, Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 1991;53(suppl):194S–200S.[Abstract/Free Full Text]
  39. Walubo A, Smith PJ, Folb PI. Oxidative stress during antituberculous therapy in young and elderly patients. Biomed Environ Sci 1995;8:106–13.[Medline]
  40. Rizzardini G, Trabattoni D, Saresella M, et al. Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS Cooperation Program. AIDS 1998;12:2387–96.[Medline]
  41. Lukwiya M, Rizzardini G, Trabattoni D, et al. Evaluation of immune activation in HIV-infected and uninfected African individuals by single-cell analysis of cytokine production. J Acquir Immune Defic Syndr 2001;28:429–36.
Received for publication September 23, 2002. Accepted for publication January 7, 2003.




This article has been cited by other articles:


Home page
 ChestHome page
E. Papageorgiou, K. Kostikas, T. Kiropoulos, E. Karetsi, G. Mpatavanis, and K. I. Gourgoulianis
Increased Oxidative Stress in Exudative Pleural Effusions: A New Marker for the Differentiation Between Exudates and Transudates?
Chest, November 1, 2005; 128(5): 3291 - 3297.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madebo, T.
Right arrow Articles by Berge, R. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madebo, T.
Right arrow Articles by Berge, R. K
Agricola
Right arrow Articles by Madebo, T.
Right arrow Articles by Berge, R. K

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS